Breakthrough 25-minute COVID-19 test set for launch by British biotech firm
On 15th October 2020, Business Leader magazine reported that our breakthrough test for COVID-19 which works in just 25 minutes, with high accuracy and requiring only routine laboratory equipment, is currently in the final stages of clinical validation. MicrosensDx...
MicrosensDx partners with Circular 1 Health to test 5,000 BAE Systems employees for COVID-19
As reported in the Financial Times on 13th October 2020, MicrosensDx’s COVID-19 LAMP Assay portable diagnostic kit is one of the rapid tests being used by health logistics company Circular 1 Health to enable over 5,000 BAE Systems employees to return to work at its...
MicrosensDx CEO interviewed by Technology Networks about RapiPREP® COVID-19 rapid diagnostic test
Following MicrosensDx's announcement of the publication of clinical data on its rapid testing kit for COVID-19 with the potential to transform detection methods, CEO Dr Christopher Stanley was interviewed by Anna MacDonald at Technology Networks to learn more about...
MicrosensDx clinical study partner, Dr Claire Steves, interviewed on Sky News
Following the clinical validation of the MicrosensDx RapiPrep® COVID-19 clinical diagnostic test, one of the lead researchers in the clinical study, Dr Claire Steves of Kings College London, was interviewed on Sky News. When asked about the benefits of the test, Dr...
MicrosensDx announces a portable coronavirus testing kit for research use that takes less than 25 minutes from taking a sample to test result
London, 20th March 2020 With the imminent threat of the coronavirus (SARS-CoV-2) forcing countries worldwide into lockdown and putting a severe strain on healthcare services, MicrosensDx has responded by adapting its current range of infectious disease rapid detection...
MicrosensDx announces first clinical results of its rapid testing kit for SARS-Cov-2
London, 31st March 2020 On 20th March MicrosensDx announced that it had launched its fast and safe molecular test for research use in the detection of RNA from the SARS-Cov-2 virus in sputum, throat and nose swabs. MicrosensDx can now announce that the test has been...